UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013938
Receipt number R000016250
Scientific Title Study of analgesic and sedative effects of suppository yokukansan for pediatric patient with postoperative tonsillectomy
Date of disclosure of the study information 2014/05/13
Last modified on 2015/08/27 16:05:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of analgesic and sedative effects of suppository yokukansan for pediatric patient with postoperative tonsillectomy

Acronym

Study of analgesic and sedative effects of suppository yokukansan for pediatric patient with postoperative tonsillectomy

Scientific Title

Study of analgesic and sedative effects of suppository yokukansan for pediatric patient with postoperative tonsillectomy

Scientific Title:Acronym

Study of analgesic and sedative effects of suppository yokukansan for pediatric patient with postoperative tonsillectomy

Region

Japan


Condition

Condition

Pediatric patient with
tonsillectomy

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to clarify an analgesic and sedative effect of yokukansan in pediatric patient with postoperative tonsillectomy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of sedation score 0,6 and 12 hours after leaving from operating room between the two groups.
Sedation score: Behavioral Observational Pain Scale (BOPS) and Children's Hospital Eastern Ontario Pain Scale (CHEOPS)

Key secondary outcomes

Comparison of the Used amount of analgesics between the two groups


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Group T: The subjects in the group T are received yokukansan suppository (0.25g/kg) during operation.

Interventions/Control_2

Group F: The subjects in the group F are injected fentanyl (0.005mg/kg) during operation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 years-old <=

Age-upper limit

12 years-old >=

Gender

Male and Female

Key inclusion criteria

a) Pediatric patient with tonsillectomy under general anesthesia
b) Patients that a written informed consent was obtained to participate in this study.

Key exclusion criteria

a) Patients who take herbal medicines
b) Patients who are allergic to medicines, or foods related to the test material of this trial
c) Patients who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial
d) Patients who are judged not suitable to participate in this trial by physician.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryoko Kawahara

Organization

Nissay Hospital

Division name

Anesthesiology

Zip code


Address

6-3-8, Itachibori, Nishi-ku, Osaka, 550-0012

TEL

06-6543-3581

Email

kawahara.ryoko@nissay-hp.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryoko Kawahara

Organization

Nissay Hospital

Division name

Anesthesiology

Zip code


Address

6-3-8, Itachibori, Nishi-ku, Osaka, 550-0012

TEL

06-6543-3581

Homepage URL


Email

kawahara.ryoko@nissay-hp.or.jp


Sponsor or person

Institute

Nissay Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 05 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2011 Year 06 Month 02 Day

Date of IRB


Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 05 Month 12 Day

Last modified on

2015 Year 08 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016250


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name